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ABSTRACT  Interest in the glycosphingolipid galactocerebroside (GC) is based on the consensus 
that in the nervous system it is expressed only by myelin-forming Schwann cells and oligoden- 
drocytes, and that it has a specific role in the elaboration of myelin sheaths. 
We  have  investigated  GC  distribution  in two rat nerves--the  sciatic,  containing a  mixture 
of myelinated and non-myelinated axons, and the cervical sympathetic trunk, in which >  99% 
of axons are non-myelinated.  Immunohistochemical  experiments using mono- and polyclonal 
GC  antibodies  were  carried  out  on  teased  nerves  and  cultured  Schwann  cells,  and  GC 
synthesis  was  assayed  biochemically.  Unexpectedly,  we  found  that  mature  non-myelin- 
forming  Schwann cells in situ and in  short-term cultures express unambiguous GC immuno- 
reactivity,  comparable in intensity to that of myelinated fibers or myelin-forming cells in short- 
term cultures. GC synthesis was also detected  in both sympathetic trunks and sciatic nerves. 
In the developing sympathetic trunk, GC was first seen at day 19 in utero, the number of GC- 
positive cells rising to ~95% at postnatal day 10. In contrast, the time course of GC appearance 
in  the  sciatic  nerve  shows two  separate  phases of  increase,  between  day  18  in  utero  and 
postnatal  day  1,  and  between  postnatal  days 20 and  35,  at which  stage  ~94%  of the  cells 
express  GC.  These  time  courses  suggest  that  Schwann  cells,  irrespective  of  subsequent 
differentiation  pathway, start expressing GC at about the same time as cell division stops. 
We suggest that GC is a ubiquitous component of mature Schwann cell membranes in situ. 
Therefore, the role of GC needs to be reevaluated,  since its function  is clearly not restricted 
to events involved  in myelination. 
Galactocerebroside (GC)' is a simple glycosphingolipid that, 
because it is the major glycolipid of the myelin sheath,  has 
been the subject of numeroug studies.  It has generally been 
assumed that in the  nervous system, only oligodendrocytes 
and myelin-forming Schwann cells express this molecule, and 
that it is absent even from closely related cells such as non- 
myelin-forming Schwann cells.  GC has therefore assumed a 
specific importance in studies on myelin and myelin forma- 
tion ( 16, 18, 20-22). Our recent studies reported below suggest 
that this view is incorrect. Unexpectedly, we find that GC is 
expressed by non-myelin-forming Schwann cells in adult rat 
peripheral nerves, and is therefore not restricted to myelin- 
forming cells. 
~  Abbreviations  used in  this paper.  GC,  galactocerebroside; GFAP, 
glial fibrillary acidic protein. 
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The  possibility  that  GC  is  a  universal  component  of 
Schwann cell plasma membranes appears not to have been 
seriously investigated before. The association of this molecule 
with oligodendrocytes and myelin-forming Schwann cells is, 
however, well documented. GC comprises -15% of the mye- 
lin  lipid  in  the  rat central  nervous system (8)  and  can  be 
localized immunohistochemically over myelin sheaths in tis- 
sue sections  from both the  central  and  peripheral  nervous 
systems (25). 
We  have  shown  previously that  even  in  the  absence  of 
axonal contact, oligodendrocytes express GC for many weeks 
in culture, and the molecule can therefore be used as a specific 
surface marker for these cells in dissociated cell cultures from 
the central nervous system (16,  21).  GC can also be demon- 
strated  immunohistochemically  on  the  surface  of myelin- 
1135 forming Schwann cells after they have been removed from 
axonal contact and plated out in tissue culture. Under these 
conditions, however, Schwann cells, unlike oligodendrocytes, 
gradually stop expressing GC during the first few days in vitro 
(16).  In  development, both oligodendrocytes and Schwann 
cells  start  expressing GC  significantly before other myelin 
components,  such  as  sulfatide  and  basic  protein,  can  be 
detected (22, 28). 
On the basis  of the present results,  the role of GC in the 
nervous system needs to be  reevaluated.  We  suggest  that, 
rather than being uniquely associated with myelin and myelin- 
forming cells, GC is in fact a ubiquitous component of  mature 
Schwann cell membranes in situ. Clearly, therefore, the func- 
tion of this glycolipid is not restricted to events involved in 
myelination. 
MATERIALS  AND  METHODS 
Teased Nerve Preparations 
Cervical sympathetic trunk and sciatic nerves from Sprague Dawley rats of 
various  ages were excised, placed  in a  small amount of phosphate-buffered 
saline (PBS), and partially teased into nerve bundles and individual fibers under 
the dissecting microscope, using fine syringe needles. In routine  experiments, 
samples were allowed to air dry before immunofluorescent  staining.  In two 
experiments,  the  results obtained  on dried  nerves  using GC antibodies  (see 
below) were confirmed using wet, partially teased sympathetic trunks. 
Cell Cultures 
Cervical sympathetic trunk and sciatic nerves were removed from Sprague 
Dawley rats of various ages, ranging from embryonic day  15 to postnatal  day 
35. The tissues were dissociated in trypsin alone,  or trypsin and collagenase, 
and were cultured  on poly-L-lysine-coated glass coverslips essentially as de- 
scribed previously for sciatic nerves (5). The nerves from 15- and 16-d embryos 
were digested in 0.05% trypsin in Eagle's minimum essential medium plus 0.02 
M HEPES, pH 7.4, for 25 min at 37"C before dissociation. Nerves from older 
embryos and postnatal rats were digested for times ranging from 5 min to 1 h 
in 0.15% collageuase (type If, Flow Laboratories  Ltd., Irvine, UK) in Eagle's 
minimum essential medium plus 0.02 M HEPES followed by addition of  0.05% 
trypsin in the same medium for a further  15 min before dissociation. 
Antibodies 
Ascites fluid containing  mouse monoclonal  antibody to GC was produced 
and characterized by Dr. B. Ranscht  (22). It is of the lgG3 subclass and was 
used at dilutions  of 1:100 to  1:1,000. Clear visualization of GC on cultured 
cells was obtained at dilutions as low as 1:1,000. In teased nerves, a dilution of 
1:200 was most often used, although GC could also be visualized using more 
dilute  antibody  solutions.  Concentrated  hybridoma  supernatant  containing 
mouse monoclonal  antibody, 01, to GC (23) was used at a dilution  of 1:100. 
Rabbit  antiserum  to GC  (21, 22)  was  used  at  a  dilution  of  1:50. Rabbit 
antiserum to human glial fibrillary acidic protein (GFAP) was produced by Dr. 
R. Pruss. Its specificity has been described elsewhere (12), and it was used at a 
dilution of l:l,000 or 1:2,000. Rabbit antiserum to cow S-100 protein (DAKO 
Immunoglobulins  a/s, Copenhagen, Denmark) was used at a dilution of 1:200. 
Rabbit antiserum  to Po was produced  and characterized by Dr. J. P. Brockes 
(6). Rhodamine conjugated to goat anti-mouse Ig (Cappel Laboratories, Coch- 
ranville, PA), adsorbed with rabbit Ig to remove cross-reacting antibodies, was 
used  at  a  dilution  of  1:100. Fluorescein  conjugated  to goat  anti-rabbit  Ig 
(Nordic Laboratories, Ltd., Maidenhead,  Berks, UK), adsorbed with mouse Ig 
to remove cross-reacting antibodies, was used at a dilution  of 1:100. Control 
antibodies used were either normal mouse ascites (1:20 and 1:200) or myeloma 
AG8 ascites (1:200), in the case of GC antibodies, and normal rabbit serum at 
appropriate dilutions for the other antibodies used. 
Immunofluorescence 
TEASED NERVES:  Immunostaining  was done at room temperature.  An- 
tibodies were diluted in PBS containing  10% fetal calf serum and 0.1 M lysine. 
PBS was used for washes, and Citifluor (City University, Northampton Square, 
London)  was used as an anti-fade mounting medium.  The preparations  were 
incubated  with mouse monoclonal  GC antibodies  for  l  h, washed, and then 
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incubated with goat anti-mouse Ig rhodamine  for 1 h, washed, and then fixed 
for  10 min in 95% ethanol/5%  acetic acid at -12"C. Most often the  nerves 
were then washed and treated for 20 rain at room temperature  in 0.3% Triton 
X-100 in PBS, since this  maximized  the  GC fluorescence. This was not a 
necessary step for visualization of GC in teased nerves, and this treatment  had 
no effect on GC fluorescence in cultured  Schwann cells. Some preparations 
were mounted at this stage. In other experiments, after staining with antibodies 
to GC, the nerves were double labeled using rabbit antibodies to GFAP or Po, 
essentially as described previously (13). 
DISSOCIATED CELL CULTURES:  Single-anddouble-labelimmunoflu- 
orescence experiments  using antibodies  to GC,  Po, and S-100 were done  as 
described previously (5, 16). 
GC Synthesis 
Cervical sympathetic trunks (total 36 nerves) or sciatic nerves (total 2 nerves) 
were dissected from 8-10-d-old  Sprague Dawley rats, desheathed, and placed 
in Eagle's minimum essential medium plus 0.02 M HEPES, pH 7.4. They were 
then chopped into small ( 1-5 mm) fragments and placed in 0.5 ml of  Dulbecco's 
modified Eagle's medium containing  10% fetal calf serum and 50 ~Ci of [~H]- 
galactose (10.4 Ci/mmol; Amersham International  plc, Amersham, UK). The 
nerves  were placed  for 5  h  at  37"C in  95%  air/5%  CO2  in  a  humidified 
incubator.  They were then separated from radioactive medium by centrifuga- 
tion (1,000 g for 5 min), washed three times in PBS, resuspended in 0.25 ml of 
PBS, and homogenized by hand in a small glass homogenizer. A small volume 
of each sample was removed for protein estimation. Lipids were then extracted 
using the system described by Brammer and Carey (4). GCs and glucocerebro- 
sides (Sigma Chemical Co., St. Louis, MO) were added to the chloroform phase 
containing  the radioactive  lipids at a  concentration  of 200  ug/ml to act as 
carriers before the samples were dried down in a stream  of N2. The extracts 
were then analyzed using two different thin layer chromatography  systems. A 
chloroform/methanol/water  ( 17:7:1 ) system using Silica Gel 60 thin layer plates 
(E.  Merck, Darmstadt,  FRG) was used to separate  cerebrosides from  other 
lipids, and a chloroform/methanol/water (60:17:2) system and Silica Gel 60 
plates impregnated  with  1%  sodium tetraborate  were used to separate GCs 
from glucocerebrosides (3). After chromatography, carrier lipids were visualized 
with iodine  vapor and the  appropriate  regions of the  plate scraped  off and 
counted in Aquasol (New England Nuclear, Dreieich, FRG) in a liquid scintil- 
lation counter. 
Protein Estimation 
Protein was estimated using the Lowry procedure (15). 
RESULTS 
GC in Teased Nerves 
The cervical sympathetic trunk,  in  which  >99%  of the 
axons are enveloped by non-myelin-forming cells (2), and the 
sciatic nerve, which contains a mixture of myelin and non- 
myelin forming cells, were removed from 17-25- and 32-38- 
d-old rats, respectively, teased with fine syringe needles onto 
microscope slides,  and air dried. This separated individual 
fibers and exposed Schwann cell surfaces. These preparations 
were then treated with monoclonal GC antibodies to locate 
GC,  and  polyclonal antibodies  against  the  myelin-specific 
protein Po to visualize myelin. Surprisingly, we found that in 
both nerves the distribution of GC and Po was  only partly 
overlapping. This was most obvious in the sympathetic trunk. 
Here, the GC antibodies revealed an unambiguous, speckled 
immunostaining covering most or all of the fibers. Collagen 
fibers and blood vessels were unstained (Fig.  1). In contrast, 
the Po antibody labeled only the occasional fiber, in agreement 
with morphological data.  Thus, the overwhelming majority 
of the GC-positive fibers were Po-negative unmyelinated Ra- 
mak fibers. 2 Similarly, in the sciatic nerve, GC immunoreac- 
2 The term unmyelinated fiber is used synonomously with the term 
Remak fiber and refers to a complex of several non-myelinated axons 
and  the  Schwann cell  that they  share.  An  unmyelinated  (Remak) 
fiber thus usually contains more than one axon. The term myelinated 
fiber designates one axon and its myelin sheath. FIGURE  1  Double-label  immunofluorescence  using antibodies to  GC  and  Po in  a  teased preparation of cervical  sympathetic 
trunk  from  10-d-old  rats.  (a) Rhodamine optics to visualize GC.  (b) Fluorescein optics to visualize Po. (c)  Phase contrast.  Note 
speckled GC-positive fiber bundles, which are Po-negative, indicating that they are unmyelinated fibers. ×  600. 
FIGURE  2  Double-label immunofluorescence using antibodies to GC and Po in a teased preparation of sciatic nerve from 35-d- 
old rats.  (a) Rhodamine optics to visualize GC. (b) Fluorescein optics to visualize Po. (c) Phase contrast. Note that many fibers are 
both GC-positive and Po-positive, indicating that they are myelinated, but several unmyelinated fibers are GC-positive and  Po- 
negative. Three arrows indicate the course of one such  unmyelinated GC-positive, Po-negative fiber, and the asterisk indicates 
another, x  600. 
tivity was not restricted to the many Po-positive  myelinated 
fibers,  but also covered Po-negative  fibers,  which by phase 
contrast conformed morphologically to non-myelin-forming 
cells (Fig. 2). 
The identity of the GC-positive, Po-negative  fibers as Re- 
mak fibers was confirmed in double-label experiments using 
the monoclonal GC antibodies, this time together with rabbit 
antiserum raised against GFAP. This procedure took advan- 
tage of the observation that, in rat nerves, GFAP fdaments 
are present in  non-myelin-forming Schwann cells only (14, 
30). In these experiments, the myelin-forming Schwann cells, 
generally identifiable by phase contrast, were GFAP-negative. 
Most of the GFAP-positive non-myelinated fibers,  however, 
were GC-positive (Figs. 3 and 4). 
GC on 5chwann Cells after 3 h in Culture 
To confirm the  results obtained from teased nerves, we 
studied GC expression by Schwann cells  in dissociated cell 
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trunk from 10-d-old rats. (a) Rhodamine optics to visualize GC. (b) Fluorescein optics to visualize GFAP. (c) Phase contrast. Note 
the overlap between GC-positive and GFAP-positive fluorescence  in the two unmyelinated fiber bundles in which the Schwann 
cell nuclei can be seen prominently in the phase-contrast micrograph  (c). x  600. 
FIGURE 4  Double-label immunofluorescence using antibodies to GC and GFAP in a teased preparation of sciatic nerve from 35- 
d-old rats. (a) Rhodamine optics to visualize  GC.  (b) Fluorescein optics  to visualize  GFAP. (c)  Phase contrast.  Note the large 
number of GC-positive fibers, representing both myelinated and unmyelinated fibers. The open arrow points to a GC-positive, 
GFAP-positive unmyelinated fiber, with the Schwann cell nucleus clearly visible in the phase-contrast micrograph (c). x  600. 
cultures.  Significant loss of GC expression due to  removal 
from axonal contact (see below and reference 16) was avoided 
by staining the cells after only 3 h in culture. In double-labeled 
immunohistochemical  experiments,  using  the  monoclonal 
GC antibody and  S-100  as a  specific Schwann cell marker 
(see Materials and Methods), 95 +_ 0.85% (mean +_ SEM) of 
the  Schwann  cells in  cultures  from the  sympathetic trunk 
removed from 10-d-old animals expressed GC (total of 1,066 
cells counted, n = 4). Less than 0.5% of the Schwann cells in 
these cultures  expressed Po,  and  therefore represented cells 
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that in situ had formed myelin. In the same type of experiment 
on sciatic nerve cultures obtained from 35-d-old animals, 94 
+  0.92% (mean +__ SEM) of the Schwann cells expressed GC 
(total of 1,010 cells counted, n =  4) (Figs. 5, 6, and 7). 
The monoclonal GC antibody also recognizes psychosine 
in  an  ELISA assay (22).  We therefore checked  our  results 
using a GC antiserum that does not recognize psychosine and 
that has been used by us in previous studies on GC (21,  22). 
In double-label immunofluorescence experiments using the 
monoclonal  and  polyclonal  GC  antibodies,  >90%  of the FIGURE 5  Double-label immunofluorescence using  antibodies to  GC  and  S-100 in  a  dissociated  cell culture from  cervical 
sympathetic trunk from 10-d-old rats, 3 h after plating. (a) Rhodamine  optics to visualize GC (b) Fluorescein optics to visualize S- 
100. (c)  Phase contrast.  Note the four GC-positive, S-100-positive Schwann cells, and one GC-negative,  S-100-negative cell, 
presumably a fibroblast (arrowed). x  600. 
FIGURE 6  Double-label  immunofluorescence  using antibodies  to GC and Po in a dissociated cell culture from cervical sympathetic 
trunk from lO-d-old rats, 3 h after plating. (a) Rhodamine optics to visualize GC. (b) Fluorescein optics to visualize Po. (c) Phase 
contrast.  Note  the  single  GC-positive,  Po-positive Schwann  cell  (arrowed),  surrounded  by  several  GC-positive,  Po-negative 
Schwann cells. One cell, probably a fibroblast,  is unlabeled with either antibody, x  600. 
Schwann cells were double labeled in each of three separate 
experiments, indicating that these Schwann cells do indeed 
express GC. We also used another monoclonal antibody, 01, 
against  GC  (23)  to  confirm  the  results  obtained  on  the 
Schwann cell cultures from the sympathetic trunk. 
GC Synthesis from [3H]Galactose 
To demonstrate that GC synthesis could occur in the nerves 
of the cervical sympathetic trunk, we incubated freshly dis- 
sected trunks with  [SH]galactose  to see whether they could 
incorporate it into  GC; parallel experiments were done on 
sciatic nerves. 
[SH]Galactose was  clearly  incorporated  into  GC  in  the 
cervical sympathetic trunk and sciatic nerve under the con- 
ditions  used.  To  establish  the  identity  of the  radiolabeled 
lipids, two different thin layer chromatography systems were 
used (see Materials and Methods). The first of these systems, 
using  Silica Gel  60  plates and  chloroform/methanol/water 
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FIGURE  7  Development of  GC-positive  Schwann  cells  in  sciatic 
nerve and cervical sympathetic trunk. Sciatic nerves (I) and cervical 
sympathetic trunks ([3) from rats of different ages were dissociated 
and double labeled with antibodies to GC and S-100 after 3  h  in 
culture as described in Materials and Methods. The percentage of 
GC-positive  Schwann  cells  at  each  time  point  is  shown  on  the 
graph.  Results at each time point were obtained from a minimum 
of three experiments, with a total of at least 1,000 Schwann cells 
counted. 
TABLE  I.  Percentage  Distribution  of Radioactivity  between Lipid 
Classes 
Sympathetic 
Lipid classes  Sciatic nerves  trunks 
A. Distribution of label be- 
tween phospholipids 
and cerebrosides 
Cerebrosides  85.5 _  3.2% 
Ethanolamine phosphoglyc-  3.6 +  0.9% 
erides 
Sulfatide  8.6 +  1.8% 
Choline, serine, and inositol  2.3 +  1.9% 
phosphoglycerides 
B. Distribution of label within 
cerebrosides 
Galactocerebrosides  82.0 ___ 2.1% 
Glucocerebrosides  18.9 ___ 2.4% 
74.8 ___ 4.5% 
11.1  +  2.5% 
7.5 ___ 4.3% 
6.7 ___ 10.3% 
59.3 _  9.4% 
40.7 +  9.4% 
Results are the means +  SEM of four experiments done on separate 
preparations of sciatic nerves or sympathetic trunks. 
( 17:7:1) as the developing solvent, separates cerebrosides from 
other lipid classes,  but results in the co-migration of gluco- 
and galactocerebrosides. A  second system, using borate-im- 
pregnated plates, is required to effect separation of the two 
classes of cerebroside. Chloroform-soluble radioactive lipids 
were examined using both of these systems, and the zones co- 
migrating with authentic cerebrosides and other lipids were 
analyzed  for  radioactivity.  The  percentage  distribution  of 
radioactivity between lipid classes is shown in Table I. Table 
I, A shows that, using the first of the two systems described 
above, the bulk of  the radioactivity co-migrates with authentic 
cerebroside after incubation of either sympathetic trunks or 
sciatic nerves with labeled galactose. Table I, B indicates that 
most of the radioactivity co-migrating with  cerebroside on 
nonimpregnated silica gel plates is recovered in the same zone 
as authentic GC standard when cerebrosides are subfraction- 
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ated using borate-impregnated plates. The absolute levels of 
incorporation  of radioactive  galactose  into  GC  in  sciatic 
nerves and  cervical sympathetic trunks  were 229.6  _+  48.5 
dpm/pg protein and 75.1 +  14.6 dpm/pg protein, respectively 
(mean  _+  SEM,  n  =  3),  giving a  ratio of incorporation  in 
sciatic nerve to cervical sympathetic trunk of 3.04. In addition 
to GC, radioactive sulfatide was also formed in sciatic nerves 
at levels of 29 +  8.5 dpm/pg protein and in cervical sympa- 
thetic trunks at levels of 5 +  1.8  dpm/#g protein (mean + 
SEM, n = 3). It is known that in vivo sulfatide is formed from 
GC. 
Although  both  sympathetic trunks  and  sciatic  nerve are 
deafly synthesizing GC, the relative proportion of glucocere- 
broside is higher in the sympathetic trunks than in the sciatic 
nerve (see Table I). Glucocerebroside is a precursor of gan- 
giiosides and appears to be formed mainly in neuronal cell 
bodies (3).  Scattered  neuronal  cell  bodies are  often  found 
along the sympathetic trunk but are absent from the sciatic 
nerve. 
Development of GC  Expression in Schwann Cells 
The developmental appearance of GC expression was stud- 
ied using dissociated cultures maintained for 3 h before im- 
munostaining as described above. The results are shown in 
Fig. 7. Briefly, in the sympathetic trunk, GC expression was 
first detected  at embryonic day  19,  whereas  in  the  sciatic 
nerve GC first appeared at embryonic day 18. The maximum 
number of GC-positive cells in  the  sympathetic trunk  was 
reached at  10-d  postnatal, whereas in  the  sciatic nerve the 
number of GC-positive Schwann cells continued to rise until 
postnatal day 35. 
Regulation of GC  Expression in Non-Myelin- 
forming Schwann Cells 
To study the regulation of GC expression in non-myelin- 
forming  cells,  two  types  of  experiments  were  done  on 
Schwann cells from the sympathetic trunk. 
First, we investigated whether GC would appear develop- 
mentally on schedule in Schwann cells removed from axonal 
contact  at  embryonic  day  18,  i.e.,  ~1  d  before  the  first 
Schwann cells normally start expressing the molecule in situ. 
Dissociated cell cultures prepared from trunks removed from 
18-d-old embryos were maintained for 13 d (reaching an age 
equivalent  to  postnatal  day  10). No  GC  was  detected  in 
immunostaining of these cultures. 
Second,  we  determined  whether  non-myelin-forming 
Schwann cells that had acquired GC during normal develop- 
ment maintained this expression when they were removed 
from axonal  contact  and  grown  in  culture.  Cultures  were 
prepared from  10-d-old sympathetic trunks,  at which  stage 
~95% of the Schwann cells are GC-positive, and maintained 
for 4 d. GC expression was monitored during this period using 
S-100 as a Schwann cell marker in double-label immunoflu- 
orescence experiments. The results are expressed in Fig.  8. 
They show that the number of Schwann cells that express GC 
steadily declines under these conditions, reaching zero after 
~3 d.  Similar experiments were done on the Schwann cells 
from sciatic nerves, also removed from animals at a  stage 
when GC expression was fully developed, in this case at 35 d. 
GC disappeared from these cultures with a time course similar 
to that seen in the sympathetic trunk (Fig. 8). 100 
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FIGURE  8  Disappearance of GC from Schwann cells in dissociated 
cell cultures of sciatic nerve (e) and cervical sympathetic trunk ([-1). 
Cells  were labeled with antibodies to GC and S-100 at different 
times in vitro as decribed in Materials and Methods. Results at each 
time point were obtained from a minimum of three experiments 
with a total of at least 1,000 Schwann  cells counted. 
DISCUSSION 
In this paper, we show that the glycolipid GC is expressed in 
the  surface  membrane  of  mature  non-myelin-forming 
Schwann cells in situ in the rat peripheral nervous system. 
The evidence rests  on  immunohistochemical experiments, 
using both monoclonal and polyclonal GC antibodies, and is 
supported by biochemical data on GC synthesis. 
This  observation  contradicts  the  previous  consensus  of 
opinion regarding the  role and  distribution  of GC,  which 
holds that this molecule is specifically involved in some event 
connected with myelin formation. This view was based on 
several lines of evidence: GC is found in high quantities in 
the nervous system and in particular in isolated preparations 
of oligodendrocytes, while only trace amounts  are present 
elsewhere, and constitutes ~ 15% of the total lipid found in 
myelin (e.g., references 8, 18, and 20). In tissue sections from 
brain and peripheral nerves, GC immunoreactivity is associ- 
ated with myelin sheaths, whereas in these experiments no 
immunoreactivity is described elsewhere (25).  Furthermore, 
GC largely co-distributes with the myelin-associated protein 
Po among Schwann cells in early cultures of  dissociated sciatic 
nerve, taken from 4-6-d-old rats (unpublished observations). 
In similar cultures from the superior cervical ganglion, where 
myelin-forming cells are infrequent, very few Schwann cells 
expressed GC (l 6). Similarly, GC is restricted to oligodendro- 
cytes in dissociated cultures from 4-6-d-old rat brain (16, 21, 
22).  Antibodies to GC can reversibly inhibit myelination in 
culture and induce demyelination in situ (7). On the basis of 
these data, it has become accepted that synthesis and expres- 
sion of GC is a major and characteristic feature of those cells 
that elaborate myelin, i.e., oligodendrocytes  and myelin-form- 
ing Schwann cells. 
A number of factors may have contributed to the failure of 
these studies to detect GC on non-myelin-forming Schwann 
cells.  These experiments have not included nerves, such as 
the sympathetic trunk, in which non-myelin-forming cells are 
obvious, since they make up almost the whole tissue.  With 
light microscopy, such fibers are much harder to detect and 
study in those nerves in which they are found among many 
myelinated axons, as for instance in the sciatic nerve. In this 
situation it is helpful to use immunohistochemical tools that 
will selectively mark non-myelin-forming Schwann cells and 
distinguish  them  from  the  myelin-forming ones.  For this 
purpose,  we  have  used  GFAP  antibodies  to  visualize the 
GFAP-containing intermediate fdaments selectively present 
in non-myelin-forming Schwann cells in situ (14). Alternative 
markers for non-myelin-forming  Schwann cells in situ include 
the cell surface molecules Ran-2 and A5E3 antigen (13).  In 
tissue sections, the immunohistochemical visualization of  GC 
in  non-myelin-forming cells  is also  more difficult than  in 
myelin-forming cells because of the layered structure of mye- 
lin.  This  ensures that  the  quantity  of GC  surrounding  a 
myelinated axon is  many times that  associated with  non- 
myelinated fibers, even if the quantity of GC per unit area of 
membrane were similar in myelin and in the plasma mem- 
brane of the non-myelin-forming cells. 
Our developmental studies show that GC expression is a 
relatively late maturational event. In the cervical sympathetic 
trunk, GC is first detectable on day 19 in utero. The number 
of Schwann  cells  expressing the  molecule then  rises  fairly 
evenly to level off at postnatal day 10, when ~95% of the S- 
100-positive cells  are also GC positive (Fig.  7).  This time 
course is similar to that of several other maturational events 
in the same nerve. Thus, axonal diameter, total number of 
Schwann cells, and the ratio of axons to Schwann cells all 
show a postnatal phase of rapid development toward mature 
levels that ends at ~day 14. The segregation  and enclosure of 
axons by Schwann cell processes into individual troughs does 
not  coincide with  the  appearance  of GC,  since  it  occurs 
significantly earlier and is to a large extent completed by day 
7 (2). Previously, we reported that very few glial cells in the 
superior cervical ganglion expressed GC at  day 5  (16).  In 
repeat experiments, we have found that the glial cells in the 
ganglion develop GC even later than those in the sympathetic 
trunk.  Under  the  present  experimental  conditions,  using 
monoclonal GC antibodies and shorter times between cell 
plating  and  immunostaining,  -10%  of the  S-100-positive 
cells expressed GC in dissociated cultures obtained from 5-<l- 
old ganglia maintained for 3 h before staining, while full GC 
expression, or ~95%, was reached at day 35  (unpublished 
observations). 
In the sciatic nerve, the time course of GC development is 
quite different from that in the cervical sympathetic trunk 
(Fig. 7). It shows two separate phases of rapid increase--the 
first between embryonic day 19 and postnatal day 1 and the 
second approximately between days 20 and 35, at which stage 
~  94% of the S-100-positive Schwann cells also express GC. 
This time course is not similar to that of the apperance of 
myelin sheaths in this nerve. Myelin sheaths are first seen at 
postnatal day 1 and their number increases rapidly during the 
first week of life and more slowly thereafter (11, 26, 27). As 
far as can be judged from the literature, however, the first 
very rapid phase of increase in cells expressing GC coincides 
with another important development, namely the period dur- 
ing which most of  the axons that will later become myelinated 
segregate to achieve a  1:1 relationship with the Schwann cell. 
The attainment of the 1:1 ratio between axons and Schwann 
cells is presumed to be accompanied by cessation of division 
of this Schwann cell population (27).  From the qualitative 
ultrastructural  studies  of Diner (9),  Peters and  Muir (19), 
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(1,  2),  it can be inferred that Remak fibers develop signifi- 
cantly later in the sciatic nerve than in the sympathetic trunk. 
As discussed  above, their development in  the  sympathetic 
trunk appears to have reached a mature stage at day 15, while 
at  that  date  only  the  very first  mature  Remak  fibers are 
appearing in the sciatic nerve (9,  11), Similarly, Schwann cell 
proliferation, which in the trunk is largely over at day 15 (2), 
is still  significant at that date in the sciatic nerve, reaching 
very low levels by day 28 (11). Comparing our results to those 
data, we suggest that the second rise in the number of GC- 
positive cells in the sciatic nerve is related to the late emerg- 
ence of mature Remak fibers in this nerve. 
A  clue  to  how  GC  expression  may be  related  to  other 
aspects of cellular differentiation comes from studies on oli- 
godendrocytes. In these cells, there is good evidence that GC 
first appears at about the same time as cell division stops in 
the  precursor cell (10,  17,  29).  A  similar relationship  may 
exist in Schwann cells, irrespective of their differentiation into 
myelin- or non-myelin-forming cells.  If this is correct, and 
GC appears at about the time at which a mitotic immature 
cell gives rise to a  more mature postmitotic cell,  then  the 
developmental curves for GC appearance in  Fig.  7  would 
parallel the rate at which Schwann cells come out of division, 
i.e.,  their rate of maturation. In the sympathetic trunk, this 
would occur fairly evenly with time. This is compatible with 
data on the development of the number of Schwann cell units 
in this nerve, although detailed studies on mitotic frequency 
are not yet available (2). In the sciatic nerve, our data would 
predict  the  existence  of  two  periods  of  relatively  rapid 
Schwann cell maturation with the accompanying cessation of 
division and GC acquisition, i.e., between embryonic day 18 
and postnatal day 1, and between postnatal days 20 and 35. 
These  phases  would  be  separated  by  a  period  of slower 
Schwann cell maturation, i.e., between days 1 and 20. Presum- 
ably the increase in the number of GC-positive cells during 
this period is slow enough to be balanced by ongoing division 
of GC-negative cells, thus causing the relative number of GC- 
positive Schwann cells to stay approximately constant. As in 
the  sympathetic trunk,  this  hypothesis  is  compatible with 
previous studies on myelination and development of Remak 
fibers in the sciatic nerve (9,  1 l,  19,  26,  27),  but cannot be 
vigorously tested  by comparison with  existing data.  Those 
studies on Schwann cell proliferation in the rat sciatic nerve 
that we are aware of deal mostly with the period between days 
1 and  15 and do not provide data of the type needed to test 
our suggestion.  We  are at  present  using  a  combination of 
[3H]thymidine  injections  and  GC  immunostaining  to  test 
more directly whether cessation of division is accompanied 
by GC  expression  in  the  three  Schwann  cell  populations 
studied here. 
Our results suggest that an axonal signal is needed to trigger 
and maintain GC expression in non-myelin-forming Schwann 
cells,  as in  myelin-forming cells.  It is therefore likely that, 
contrary to current thought, the signal that induces GC expres- 
sion is different from the myelination signal.  There is some 
evidence from experiments done on sciatic nerve cultures that 
the signal triggering GC expression operates via an increase 
in intracellular cyclic AMP levels (23).  In these experiments, 
GC could be recalled in  a  proportion of Schwann  cells in 
dissociated cell cultures that had previously lost GC expres- 
sion in vitro, by exposing the cells to high concentrations of 
cyclic AMP derivatives. We have found that similar results 
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can be obtained using Schwann cell cultures obtained from 
the sympathetic trunk of 10-d-old  rats, although >99.5% of 
the Schwann cells in these cultures derive from non-myelin- 
forming cells (unpublished observations). 
More GC was synthesized from [3H]galactose  per micro° 
gram  of protein  in  excised  sciatic  nerves than  in  cervical 
sympathetic trunks. In the sciatic nerve, 80% of the fibers are 
myelin-forming, whereas 20% are Remak fibers (11). On the 
basis of counts in the cervical sympathetic trunk that 99% of 
the axons are unmyelinated (2) and that there are on average 
5.7  axons per Schwann cell  in mature Remak fibers and  1 
axon per Schwann cell in the myelinated fibers (1), it can be 
estimated that only 5-6% of  the fibers in this nerve are myelin- 
forming. Furthermore, it seems reasonable to assume that the 
rate of GC synthesis in 8- I 0-d-old rats might be considerably 
higher in myelin than in non-myelin-forming Schwann cells, 
given the multilameUar nature of the myelin sheath and the 
need  to  make  large  quantities  of myelin  membrane.  It is 
therefore not surprising that GC synthesis is higher per micro- 
gram of protein in the sciatic nerve than in the trunk.  The 
difference between the two is only threefold, however, making 
it very unlikely that the Schwann cells surrounding the my- 
elinated axons in  the trunk  are responsible for all the GC 
synthesis observed, and supporting the idea that a significant 
proportion of the synthesis is contributed by the  Schwann 
cells of the unmyelinated fibers. 
Apart from being one of the building blocks of the myelin 
sheath,  the  functional role of GC is still  unclear.  Develop- 
mentally,  it appears on the  surface of non-myelin-forming 
Schwann  cells  as they reach  maturity and  is expressed by 
oligodendrocytes and myelin-forming Schwann  cells  as cell 
division stops but before the onset of myelination. This points 
to an involvement in  those  membrane-membrane interac- 
tions that establish the  mature  relationship  between axons 
and their glial cells,  quite apart from any specific role this 
lipid may have in the membrane-wrapping events involved 
in myelination. 
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